|
PRECISION PEPTIDE COMPANY INC
US OTC SYMBOL: PNGAF
Canada: PNGA
Last Price: .33 | Website | SEC Filings | Latest News
Disseminated on behalf of Precision Peptide Company Inc.
Subscribers, we told you to watch PNGAF!
TODAY the company just announced an EXCLUSIVE Strategic Marketing Partnership with Mixed Martial Arts Group Limited, one of the world's largest digitally connected combat sports ecosystems.
We're talking 5 MILLION social media followers, 530,000 user profiles, 75,000+ active students, and 800+ verified gyms GLOBALLY. Under this deal, PNGAF's peptide products will be marketed and sold directly to every single one of MMA's subscribers. That's not a small audience — that's a distribution channel most consumer wellness companies would KILL for.
And think about WHO this audience is... combat sports athletes, MMA fighters, gym rats, weekend warriors — the exact demographic that has been using injectable peptides like BPC-157 for years. These are the people who already KNOW what peptides do. Now they're about to discover a needle-free patch version for the first time.
PNGAF isn't just building a product — it's building a pipeline straight to its most natural customer base on earth. If you weren't watching this one before... you need to be watching it NOW.
|
The Precision Peptide Company Inc. Announces Exclusive Strategic Marketing Partnership with Mixed Martial Arts Group Limited
Tue, May 12, 2026 at 7:30 AM EDT
Vancouver, British Columbia--(Newsfile Corp. - May 12, 2026) - The Precision Peptide Company (CSE: BPC) (OTCQB: PNGAF) (the "Company" or "BPC"), a publicly traded wellness company focused on advanced peptide formulations and delivery systems, today announces that it has entered into an Exclusive Strategic Marketing Agreement (the "Strategic Marketing Agreement") dated May 8, 2026 with Mixed Martial Arts Group Limited ("MMA"), a New South Wales, Australia-based company.
Under the Strategic Marketing Agreement, the parties have entered into an exclusive partnership for the purposes of marketing and selling the Company's peptide products to MMA's subscriber base. MMA operates one of the world's largest digitally connected combat sports ecosystems, with over 5 million social media followers, with approximately 530,000 user profiles, more than 75,000 active students and over 800 verified gyms globally and will market the Company's products to all individuals and entities subscribed to MMA's platform as of the effective date and throughout the term of the Strategic Marketing Agreement.
All peptide products sold under the Strategic Marketing Agreement will be manufactured in the United States of America and will comply with all applicable U.S. regulatory requirements and standards, including those set by the U.S. Food and Drug Administration and any other applicable regulatory authority.
click here to read more
|
RFK JR. + FDA SHIFT = MASSIVE POLICY TAILWIND
Here's a catalyst that NO ONE saw coming. On April 15, 2026, the FDA officially removed 12 peptides from Category 2 (effective April 22, 2026) including BPC-157, PNGAF's flagship patch compound.
Each substance will go before the Pharmacy Compounding Advisory Committee (PCAC), with BPC-157 specifically on the July 23, 2026 PCAC agenda. This is a HUGE deal and PNGAF was one of the first public companies to respond positively.
For a stock with barely any trading activity, PNGAF could quickly be positioned to capitalize on one of the hottest trends in Health and wellness today.
Needless to say, it may not be long before all of the Street has this quiet Hidden Gem on their screens!
THE BOTTOM LINE
PNGAF just signed an EXCLUSIVE marketing deal with one of the world's largest combat sports ecosystems. That's not marketing. That's a distribution UNLOCK.
Add the FDA's April 22 removal of BPC-157 from Category 2, with a formal PCAC review scheduled for July 23, 2026... and you've got a MULTIPLE catalyst stack hitting simultaneously:
→ Product catalyst: BPC-157 needle-free patch in final testing, commercial launch imminent
→ Distribution catalyst: Exclusive MMA Group deal — 5M+ combat sports followers
→ Regulatory catalyst: FDA potentially opening the door for the entire peptide sector
When product, distribution, AND regulation all line up at once... that's when traders pay attention. Is PNGAF about to make its move?
Make sure you put PNGAF on your screen RIGHT NOW and
Follow on Twitter for Updates + Play-by-Play!
|
